Response to neoadjuvant chemotherapy among women with triple-negative breast cancer by HER2 expression status

被引：0
|
作者：
Budhathoki, Pravash
Shah, Anish
Gaire, Suman
Joshi, Utsav
Yadav, Siddhartha
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-06-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-06-05
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HER2 Expression in Triple-Negative Breast Cancer: Clinicopathologic Features and Response to Neoadjuvant Chemotherapy
    Morante, Zaida
    Otoya, Iris
    Valdivieso, Natalia
    Calle, Cindy
    Fuentes, Hugo
    Neciosup, Silvia
    Castaneda, Carlos
    Vidaurre, Tatiana
    Falla, Martin
    Colomo, Valeria
    Gomez, Henry
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [2] Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
    Domergue, Camille
    Martin, Elodie
    Lemarie, Camille
    Jezequel, Pascal
    Frenel, Jean-Sebastien
    Augereau, Paule
    Campone, Mario
    Patsouris, Anne
    [J]. CANCERS, 2022, 14 (10)
  • [3] Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Shi, Yue
    Lu, Heng
    Zhang, Yiqi
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (02) : 387 - 395
  • [4] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [5] Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer
    Goncalves, Anthony
    [J]. BULLETIN DU CANCER, 2016, 103 (06) : S76 - S89
  • [6] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    [J]. Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [7] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [8] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 74A - 74A
  • [9] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2016, 29 : 74A - 74A
  • [10] Impact of HER2 status (HER2-low versus HER2-0) on complete histologic response after neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC)
    Domergue, C.
    Martin, E.
    Lemarie, C.
    Jezequel, P.
    Frenel, J-S.
    Augereau, P.
    Campone, M.
    Patsouris, A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S428 - S429
12345